PMID: 7437237Sep 1, 1980Paper

Evaluation of indoramin added to oxprenolol and bendrofluazide as a third agent in severe hypertension

British Journal of Clinical Pharmacology
A J MarshallD W Barritt


1 Indoramin, an alpha-adrenoreceptor blocking agent has been given as a third agent to patients with severe hypertension treated with adequate doses of a beta-adrenoceptor blocking drug and a thiazide diuretic. 2 A further fall in blood pressure followed the addition of indoramin. With 75 mg twice daily this was on average a fall of 12% of mean arterial pressure in the supine position, 16% standing an 17% after exercise. 3 The rise in blood pressure caused by isometric exercise was not altered by indoramin. 4 Indoramin slowed the heart rate. On 75 mg twice daily the reduction was 14% at rest and 19% after exercise. 5 Side effects of indoramin were sedation, sleep disturbance and vivid dreams.


Aug 1, 1978·The Journal of Pharmacy and Pharmacology·K F Rhodes, J F Waterfall
Jun 1, 1979·Clinical Pharmacology and Therapeutics·G S StokesE P MacCarthy
Jun 1, 1976·British Journal of Clinical Pharmacology·G H DraffanC T Dollery
Aug 1, 1977·British Heart Journal·D W Barritt, A J Marshall
Oct 18, 1975·British Medical Journal·J C PetrieJ A Lewis
Aug 1, 1973·The Journal of Pharmacy and Pharmacology·D H Variava, P Turner
Dec 1, 1973·European Journal of Clinical Pharmacology·P J LewisC T Dollery
May 1, 1972·Clinical Pharmacology and Therapeutics·R B RoydsJ D Lockhart

❮ Previous
Next ❯


Apr 1, 1989·Cardiovascular Drugs and Therapy·P A van Zwieten

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.